Drug-drug Interaction Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Subjects With Castration-Resistant Prostate Cancer
Latest Information Update: 09 Apr 2025
At a glance
- Drugs Apalutamide (Primary) ; Fexofenadine; Midazolam; Omeprazole; Pioglitazone; Rosuvastatin; Vitamin K; Warfarin
- Indications Adenocarcinoma; Prostate cancer
- Focus Pharmacokinetics
- Sponsors Aragon Pharmaceuticals
Most Recent Events
- 05 Dec 2024 Planned End Date changed from 1 Dec 2027 to 31 Dec 2027.
- 09 Oct 2024 Planned End Date changed from 31 Dec 2024 to 1 Dec 2027.
- 17 Jul 2024 Planned End Date changed from 1 Dec 2024 to 31 Dec 2024.